XTL Biopharmaceuticals

XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals

Thursday, June 21, 2012 12:35 PM

XTL Biopharmaceuticals, an Israel-based biopharmaceutical development company, has agreed to acquire Kitov Pharmaceuticals, an Israel-based company that researches and develops combination drug products with a focus on hypertension and pain induced by osteoarthritis.

More... »


XTL Biopharma raises capital $3.5 million through institutional investors

Monday, March 19, 2012 11:14 AM

XTL Biopharmaceuticals, based in Herzliya, Israel, has successfully completed a private placement of securities with foreign and Israeli institutional and private investors for a total of $2.4 million, with a 6-month lock-up period.

More... »


XTL, Minoguard sign licensing agreement

Tuesday, March 29, 2011 11:58 AM

Israel-based XTL Biopharmaceuticals has entered into a term sheet to acquire the activity of MinoGuard, also based in Israel, by obtaining an exclusive license to use MinoGuard's entire technology in return for royalties on sales and milestone payments throughout the clinical development process.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs